Billing and Coding: Tomosynthesis-Guided Breast Biopsy
National · Effective Oct 2, 2025
1 active Medicare policy lists 19499, and 32 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Oct 2, 2025
32 policies from 12 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 19499 |
|---|---|---|
| Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Oct 1, 2026 | Covered |
| Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery | Sep 1, 2026 | Covered |
| Laser Interstitial Tumor Therapy (LITT) | Jan 1, 2026 | Covered |
| Reconstructive Breast Surgery | May 15, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|
| Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Oct 1, 2026 | Covered |
|---|
| Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery | Sep 1, 2026 | Covered |
|---|
| Laser Interstitial Tumor Therapy (LITT) | Jan 1, 2026 | Covered |
|---|
| Reconstructive Breast Surgery | May 15, 2026 | Covered |
|---|
| Policy | Effective | Status of 19499 |
|---|---|---|
| Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Oct 1, 2026 | Covered |
| Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery | Sep 1, 2026 | Covered |
| Laser Interstitial Tumor Therapy (LITT) | Jan 1, 2026 | Covered |
| Reconstructive Breast Surgery | May 15, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Oct 1, 2026 | Covered |
| Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery | Sep 1, 2026 | Covered |
| Laser Interstitial Tumor Therapy (LITT) | Jan 1, 2026 | Covered |
| Reconstructive Breast Surgery | May 15, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Breast Reconstruction Following Mastectomy or Lumpectomy | Apr 15, 2026 | Not covered |
| Cigna Commercial Other Services Code List | Mar 7, 2026 | Prior auth required |
| Cigna Comprehensive Code List | Mar 7, 2026 | Prior auth required |
| Mammary Ductoscopy, Aspiration and Lavage | Jan 15, 2026 | Not covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Breast Ductal Examination and Fluid Cytology Analysis | Jan 6, 2026 | Not covered |
| Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | Oct 1, 2026 | Covered |
| Ultrasound Ablation for Oncologic Indications | Jan 6, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Adipose-derived Stem Cell Enrichment in Autologous Fat Grafting to the Breast | Feb 1, 2026 | Covered |
| Gender Affirming Interventions for Gender Dysphoria | Apr 1, 2026 | Covered |
| Reconstructive Breast Surgery/Mastopexy, and Management of Breast Implants | Dec 1, 2025 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Brachytherapy | Mar 2, 2026 | Covered |
| Breast Procedures | Sep 3, 2025 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Cosmetic and Reconstructive Procedures | Not recorded | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Breast Reconstruction | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Breast Reconstruction | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 19499 |
|---|---|---|
| Breast Reconstruction | Jan 1, 2026 | Covered |